DK1454137T3 - Anvendelse af en mærket ligand med specificitet for det humane CD4-molekyle - Google Patents

Anvendelse af en mærket ligand med specificitet for det humane CD4-molekyle

Info

Publication number
DK1454137T3
DK1454137T3 DK02804582T DK02804582T DK1454137T3 DK 1454137 T3 DK1454137 T3 DK 1454137T3 DK 02804582 T DK02804582 T DK 02804582T DK 02804582 T DK02804582 T DK 02804582T DK 1454137 T3 DK1454137 T3 DK 1454137T3
Authority
DK
Denmark
Prior art keywords
human
specificity
molecule
bearing cells
labeled ligand
Prior art date
Application number
DK02804582T
Other languages
English (en)
Inventor
Ruediger Laub
Ullrich Pigla
Frank Emmrich
Raimund W Kinne
Original Assignee
Biotectid Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10232189A external-priority patent/DE10232189A1/de
Application filed by Biotectid Gmbh filed Critical Biotectid Gmbh
Application granted granted Critical
Publication of DK1454137T3 publication Critical patent/DK1454137T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/13Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultrasonic waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514CD4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02804582T 2001-12-11 2002-12-09 Anvendelse af en mærket ligand med specificitet for det humane CD4-molekyle DK1454137T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10160653 2001-12-11
DE10232189A DE10232189A1 (de) 2001-12-11 2002-07-16 Verwendung eines markierten Liganden mit Spezifität für das humane CD4-Molekül zur Herstellung eines Diagnostikums zur Analyse von Wanderungs- und/oder Verteilungsmustern von Zellpopulationen
PCT/EP2002/013939 WO2003050499A2 (de) 2001-12-11 2002-12-09 Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül

Publications (1)

Publication Number Publication Date
DK1454137T3 true DK1454137T3 (da) 2008-06-16

Family

ID=26010752

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02804582T DK1454137T3 (da) 2001-12-11 2002-12-09 Anvendelse af en mærket ligand med specificitet for det humane CD4-molekyle

Country Status (10)

Country Link
US (2) US20050124005A1 (da)
EP (1) EP1454137B1 (da)
JP (1) JP2005512083A (da)
AT (1) ATE386269T1 (da)
AU (1) AU2002356638A1 (da)
CA (1) CA2469901C (da)
DE (1) DE50211704D1 (da)
DK (1) DK1454137T3 (da)
ES (1) ES2301716T3 (da)
WO (1) WO2003050499A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2471543A1 (en) 2010-12-02 2012-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
RU2762315C2 (ru) 2014-09-16 2021-12-17 Юнайтед Байофарма, Инк. Лечение и функциональное излечение вич-инфекции моноклональными антителами к cd4, опосредующими конкурентное ингибирование входа вич
BR112019002734A2 (pt) 2016-08-13 2019-05-14 Ubi Ip Holdings tratamento e remissão virológica sustentada de infecção por hiv por anticorpos para cd4 em pacientes estabilizados por haart

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000560A2 (en) * 1996-07-02 1998-01-08 Massachusetts Institute Of Technology Method for determining lymphocyte distribution and trafficking in mammals using imaging
EP1118858A3 (en) * 2000-01-12 2003-07-09 Pfizer Limited Assay method

Also Published As

Publication number Publication date
EP1454137B1 (de) 2008-02-13
WO2003050499A3 (de) 2003-12-04
EP1454137A2 (de) 2004-09-08
CA2469901C (en) 2017-07-04
DE50211704D1 (de) 2008-03-27
ES2301716T3 (es) 2008-07-01
AU2002356638A1 (en) 2003-06-23
WO2003050499A2 (de) 2003-06-19
JP2005512083A (ja) 2005-04-28
CA2469901A1 (en) 2003-06-19
US20050124005A1 (en) 2005-06-09
US20110300069A1 (en) 2011-12-08
AU2002356638A8 (en) 2003-06-23
ATE386269T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
Chan Effects of combined alcohol and benzodiazepine: a review
MA31225B1 (fr) Anticorps neutralisants des cytomegalovirus humains et leur utilisation
ATE264717T1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
ATE283289T1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
EP1409544A4 (en) HUMAN DR4 ANTIBODIES AND ITS APPLICATIONS
MA27853A1 (fr) LIGANDS DES RECEPTEURS DE CANNABINOiDES ET LEURS UTILISATIONS
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
CY1115212T1 (el) Διαμεσολαβηση στην κυτταροτοξικοτητα των κυτταρων που παρουσιαζουν eπιφaneiakh εκφραση της cd44
EP1367995A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING DRUG DELIVERY ON AND IN EPITHELIAL TISSUE
BRPI0411200A (pt) método de tratamento de cáncer, métodos de tratamento de paciente humano, artigo industrializado e kit de tratamento de cáncer
MA32566B1 (fr) Anticorps neutralisant les cytomégalovirus humains et leurs utilisations
BRPI0214840B8 (pt) métodos para a detecção de mutações oncogênicas humanas, métodos automatizados para detectar uma mutação e método e ensaio para identificar um ou mais compostos tendo atividade anti-proliferativa
ATE517340T1 (de) Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren
TW200606177A (en) Glycoprotein VI antibodies and methods thereof
FI20011664A7 (fi) Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
EP1643894A4 (en) METHOD, KITS AND ANTIBODIES FOR THE DETECTION OF PARATHYROID
ATE513555T1 (de) Pharmazeutische kombination aus g-csf und plgf für blutstammzellen
EP1451552A4 (en) FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS
DK1454137T3 (da) Anvendelse af en mærket ligand med specificitet for det humane CD4-molekyle
IL190401A0 (en) Antibodies against april as biomarkers for early prognosis of lymphoma patients
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2005096706A3 (en) Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
ATE429440T1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis